Nonalcoholic Fatty Liver Disease and Health Outcomes: An Umbrella Review of Systematic Reviews and Meta-analyses

Overview

Journal Ther Adv Chronic Dis

Publisher Sage Publications

Date 2022 May 27

PMID 35620184

Authors

Lixian Zhong

Chutian Wu

Yuting Li

Qiuting Zeng

Leizhen Lai

Sisi Chen

Shaohui Tang

Affiliations

Soon will be listed here.

Abstract

Purpose: A large number of systemic reviews and meta-analyses have explored the relationship between nonalcoholic fatty liver disease (NAFLD) and multiple health outcomes. The aim of this study is to conduct an umbrella review to assess the strength and evidence for the association between NAFLD and health outcomes.

Methods: We systematically identified the present meta-analyses of observational studies reporting an association between NAFLD and health outcomes. For each meta-analysis, we assessed the quality with AMSTAR2 and graded the epidemiologic evidence.

Results: Fifty-four articles comprising 111 unique meta-analyses were included in this study. Eighty-five unique outcomes showed significant associations ( ← 0.05), whereas 26 unique outcomes showed insignificant associations, and we cannot assess the epidemiologic evidence. For 85 significant health outcomes, four outcomes (carotid intima-media thickness (C-IMT), peak A velocity, left ventricle end-diastolic diameter, incident chronic kidney disease (CKD) in adult patients) was graded as high quality of evidence, 23 outcomes were graded as the moderate quality of evidence, and the remaining 58 outcomes were graded as weak quality of evidence. Fourty-seven (87.03%) studies showed critically low methodological quality.

Conclusion: In this umbrella review, only four statistically significant health outcomes showed high epidemiologic evidence. NAFLD seems to relate to an increased risk of C-IMT, peak A velocity, left ventricle end-diastolic diameter, and incident CKD in adult patients.

Citing Articles

Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease.

Wu C, Liu X, Zhong L, Zhou Y, Long L, Yi T Oxid Med Cell Longev. 2023; 2023:9245667.

PMID: 36865349 PMC: 9974253. DOI: 10.1155/2023/9245667.

Comparison of copper concentration between non-alcoholic fatty liver disease patients and normal individuals: A meta-analysis.

Chen Y, Wu C, Li G, Wang W, Tang S Front Public Health. 2023; 11:1095916.

PMID: 36817887 PMC: 9929538. DOI: 10.3389/fpubh.2023.1095916.

References

Younossi Z . Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2018; 70(3):531-544. DOI: 10.1016/j.jhep.2018.10.033. View

Ioannidis J . Why most discovered true associations are inflated. Epidemiology. 2008; 19(5):640-8. DOI: 10.1097/EDE.0b013e31818131e7. View

Massoud O, Charlton M . Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. Clin Liver Dis. 2017; 22(1):201-211. DOI: 10.1016/j.cld.2017.08.014. View

Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne C, Targher G . Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020; 111S:154170. DOI: 10.1016/j.metabol.2020.154170. View

Liu Y, Zhong G, Tan H, Hao F, Hu J . Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis. Sci Rep. 2019; 9(1):11124. PMC: 6668400. DOI: 10.1038/s41598-019-47687-3. View

Madan S, John F, Pitchumoni C . Nonalcoholic Fatty Liver Disease and Mean Platelet Volume: A Systemic Review and Meta-analysis. J Clin Gastroenterol. 2015; 50(1):69-74. DOI: 10.1097/MCG.0000000000000340. View

Mantovani A, Dauriz M, Gatti D, Viapiana O, Zoppini G, Lippi G . Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Aliment Pharmacol Ther. 2019; 49(4):375-388. DOI: 10.1111/apt.15087. View

Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S . Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; 61(5):1547-54. DOI: 10.1002/hep.27368. View

Mahfood Haddad T, Hamdeh S, Kanmanthareddy A, Alla V . Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: A systematic review and meta-analysis. Diabetes Metab Syndr. 2016; 11 Suppl 1:S209-S216. DOI: 10.1016/j.dsx.2016.12.033. View

10.

Byrne C, Targher G . NAFLD as a driver of chronic kidney disease. J Hepatol. 2020; 72(4):785-801. DOI: 10.1016/j.jhep.2020.01.013. View

11.

Wijarnpreecha K, Panjawatanan P, Kroner P, Cheungpasitporn W, Ungprasert P . Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Ann Gastroenterol. 2020; 33(6):661-666. PMC: 7599342. DOI: 10.20524/aog.2020.0535. View

12.

Bhatia L, Curzen N, Calder P, Byrne C . Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J. 2012; 33(10):1190-200. DOI: 10.1093/eurheartj/ehr453. View

13.

Tsilidis K, Kasimis J, Lopez D, Ntzani E, Ioannidis J . Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015; 350:g7607. DOI: 10.1136/bmj.g7607. View

14.

Mantovani A, Dauriz M, Byrne C, Lonardo A, Zoppini G, Bonora E . Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis. Metabolism. 2018; 87:1-12. DOI: 10.1016/j.metabol.2018.06.004. View

15.

Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

16.

Khalid Y, Dasu N, Suga H, Dasu K, Reja D, Shah A . Increased cardiovascular events and mortality in females with NAFLD: a meta-analysis. Am J Cardiovasc Dis. 2020; 10(3):258-271. PMC: 7486530. View

17.

Neuenschwander M, Ballon A, Weber K, Norat T, Aune D, Schwingshackl L . Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies. BMJ. 2019; 366:l2368. PMC: 6607211. DOI: 10.1136/bmj.l2368. View

18.

Mantovani A, Lonardo A, Vinco G, Zoppini G, Lippi G, Bonora E . Association between non-alcoholic fatty liver disease and decreased lung function in adults: A systematic review and meta-analysis. Diabetes Metab. 2019; 45(6):536-544. DOI: 10.1016/j.diabet.2019.04.008. View

19.

Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis J . Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 348:g2035. PMC: 3972415. DOI: 10.1136/bmj.g2035. View

20.

Kaps L, Labenz C, Galle P, Weinmann-Menke J, Kostev K, Schattenberg J . Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. United European Gastroenterol J. 2020; 8(8):942-948. PMC: 7707877. DOI: 10.1177/2050640620944098. View